UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000019603
Receipt No. R000022648
Official scientific title of the study Effect of general anesthesia with sevoflurane at age-adjusted concentration on electrocorticography, compared with 2.5% in patients with intractable epilepsy
Date of disclosure of the study information 2015/11/02
Last modified on 2016/12/30 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effect of general anesthesia with sevoflurane at age-adjusted concentration on electrocorticography, compared with 2.5% in patients with intractable epilepsy
Title of the study (Brief title) Effect of sevoflurane concentration on the electrocorticography
Region
Japan

Condition
Condition intractable epilepsy
Classification by specialty
Neurology Pediatrics Anesthesiology
Neurosurgery Child
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the optimal concentration of an inhalational anesthetic for surgical treatment of intractable epilepsy
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The frequency of spikes during anesthesia
Key secondary outcomes The area where spikes are detected during anesthesia

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Electrocorticogram is recorded with the end-tidal concentration of sevoflurane at 1.5 x age-adjusted minimum alveolar concentration, followed by recording with the end-tidal concentration of sevoflurane at 2.5%, irrespective of the patients' age.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
3 years-old <=
Age-upper limit
40 years-old >=
Gender Male and Female
Key inclusion criteria Patients undergoing surgical treatment of intractable epilepsy with American Society of Anesthesiologists physical status I-III
Key exclusion criteria Patients with ischemic heart disease or decreased cardiac function with left ventricular ejection fraction equal to or less than 40%
Target sample size 50

Research contact person
Name of lead principal investigator Yutaka Oda
Organization Osaka City General Hospital
Division name Anesthesiology
Address 2-13-22 Miyakojima-Hondori, Miyakojima-ku, Osaka
TEL +81-6-6929-1221
Email odayou@s5.dion.ne.jp

Public contact
Name of contact person Yutaka Oda
Organization Osaka City General Hospital
Division name Anesthesiology
Address 2-13-22 Miyakojima-Hondori, Miyakojima-ku, Osaka
TEL +81-6-6929-1221
Homepage URL
Email odayou@s5.dion.ne.jp

Sponsor
Institute Osaka City General Hospital
Institute
Department

Funding Source
Organization Department of Anesthesiology, Osaka City General Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 11 Month 02 Day

Progress
Recruitment status Main results already published
Date of protocol fixation
2015 Year 08 Month 31 Day
Anticipated trial start date
2015 Year 11 Month 03 Day
Last follow-up date
2016 Year 10 Month 01 Day
Date of closure to data entry
2016 Year 10 Month 01 Day
Date trial data considered complete
2016 Year 10 Month 02 Day
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results The incidence and the number of leads with epileptic discharge in pediatric patients receiving 1.5 MAC sevoflurane were signifcantly larger than those receiving 2.5% sevoflurane.
Other related information

Management information
Registered date
2015 Year 11 Month 02 Day
Last modified on
2016 Year 12 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022648